Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Biol Macromol ; 278(Pt 4): 135054, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39187114

RESUMEN

Glioblastoma (GBM) resection and medication treatment are limited, and local drug therapies are required. This study aims to create a hybrid system comprising liposome-like particles (LLP-DOX) encapsulated in chitosan/hyaluronic acid/polyethyleneimine (CHI/HA/PEI) hydrogels, enabling controlled local delivery of doxorubicin (DOX) into the resection cavity for treating GBM. CHI/HA/PEI hydrogels were characterized morphologically, physically, chemically, mechanically, and thermally. Findings revealed a high network and compact micro-network structure, along with enhanced physical and thermal stability compared to CHI/HA hydrogels. Simultaneously, drug release from CHI/HA/PEI/LLP-DOX hydrogels was assessed, revealing continuous and controlled release up to the 148th hour, with no significant burst release. Cell studies showed that CHI/HA/PEI hydrogels are biocompatible with low genotoxicity. Additionally, LLP-DOX-loaded CHI/HA/PEI hydrogels significantly decreased cell viability and gene expression levels compared to LLP-DOX alone. It was also observed that the viability of GBM spheroids decreased over time when interacting with CHI/HA/PEI/LLP-DOX hydrogels, accompanied by a reduction in total surface area and an increase in apoptotic tendencies. In this study, we hypothesized that creating a hybrid drug delivery system by encapsulating DOX-loaded LLPs within a CHI/HA/PEI hydrogel matrix could achieve sustained drug release, improve anticancer efficacy via localized treatment, and effectively mitigate GBM progression for 3D microtissues.


Asunto(s)
Quitosano , Preparaciones de Acción Retardada , Doxorrubicina , Liberación de Fármacos , Glioblastoma , Ácido Hialurónico , Hidrogeles , Liposomas , Ácido Hialurónico/química , Ácido Hialurónico/farmacología , Doxorrubicina/química , Doxorrubicina/farmacología , Doxorrubicina/administración & dosificación , Glioblastoma/tratamiento farmacológico , Glioblastoma/patología , Quitosano/química , Hidrogeles/química , Humanos , Preparaciones de Acción Retardada/farmacología , Liposomas/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos
2.
Arch Toxicol ; 98(6): 1717-1725, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38684585

RESUMEN

Antibiotics, which have been used for many years to treat infections, also play an important role in food contamination with antibiotic residues. There is also unnecessary use of antibiotics, particularly to increase production efficiency. Non-compliance with withdrawal periods and maximum residue limits (MRLs) for antibiotics used in food-producing animals results in undesirable events, such as allergic reactions, teratogenicity, carcinogenicity, changes in the microbiota and, in particular, antibiotic resistance. Therefore, it may be useful to avoid unnecessary use of antibiotics, to limit the use of antibiotics and to turn to alternatives that can be used instead of antibiotics. The aim of this review is to provide information on the undesirable effects of antibiotic residues in food-producing organisms and in the environment, their determination, and the precautions that can be taken.


Asunto(s)
Antibacterianos , Residuos de Medicamentos , Contaminación de Alimentos , Antibacterianos/toxicidad , Contaminación de Alimentos/análisis , Animales , Residuos de Medicamentos/análisis , Residuos de Medicamentos/toxicidad , Humanos
3.
J Photochem Photobiol B ; 253: 112889, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38492477

RESUMEN

One of the studies on new drug delivery and release systems that has increased in recent years is the study using plasmonic nanoparticles. In this study, polydopamine nanoparticles (PDOP NPs), which contribute to photothermal drug release by near infrared radiation (NIR), were decorated with gold nanoparticles (AuNPs) to utilize their plasmonic properties, and a core-satellite-like system was formed. With this approach, epirubicin (EPI)-loaded PDOP NPs were prepared by utilizing the plasmonic properties of AuNPs. Scanning Electron Microscope (SEM), Fourier Transform Infrared Spectroscopy (FTIR), and X-ray Diffraction (XRD) methods were used to evaluate the structural properties of these particles. The release behavior of the prepared structures in acidic (pH 5.0) and neutral (pH 7.4) environments based on the ON/OFF approach was also examined. The biocompatibility properties of the particles were evaluated on mouse fibroblast (L929) and anticancer activities on neuroblastoma (SH-SY5Y) cells. The effects of prepared EPI-loaded particles and laser-controlled drug release on ROS production, genotoxicity, and apoptosis were also investigated in SH-SY5Y cells. With the calculated combination index (CI) value, it was shown that the activity of EPI-loaded AuNP@PDOP NPs increased synergistically with the ON/OFF-based approach. The developed combination approach is considered to be remarkable and promising for further evaluation before clinical use.


Asunto(s)
Indoles , Nanopartículas , Neuroblastoma , Polímeros , Animales , Humanos , Ratones , Sistemas de Liberación de Medicamentos/métodos , Liberación de Fármacos , Epirrubicina/farmacología , Oro/química , Nanopartículas del Metal/toxicidad , Nanopartículas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA